The Core Value of Cost-Effectiveness Analyses.
作者信息
Dhruva Sanket S, Krumholz Harlan M
机构信息
Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut.
Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut; Section of Cardiovascular Medicine, Yale School of Medicine; Department of Health Policy and Management, Yale School of Public Health; and Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut.
出版信息
J Am Coll Cardiol. 2016 Jan 5;67(1):39-41. doi: 10.1016/j.jacc.2015.11.013.
Abstract
摘要
相似文献
1
The Core Value of Cost-Effectiveness Analyses.成本效益分析的核心价值。
J Am Coll Cardiol. 2016 Jan 5;67(1):39-41. doi: 10.1016/j.jacc.2015.11.013.
2
Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.经导管主动脉瓣置换术使用自膨胀式人工瓣膜与外科主动脉瓣置换术的成本效益分析
J Am Coll Cardiol. 2016 Jan 5;67(1):29-38. doi: 10.1016/j.jacc.2015.10.046.
3
Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective.经导管主动脉瓣置换术治疗严重症状性主动脉瓣狭窄患者的成本效益：从加拿大角度评估爱德华兹 SAPIEN 经导管心脏瓣膜与标准治疗及外科主动脉瓣置换术的比较。
J Thorac Cardiovasc Surg. 2013 Jul;146(1):52-60.e3. doi: 10.1016/j.jtcvs.2012.06.018. Epub 2012 Jul 11.
4
Is Transcatheter Aortic Valve Implantation as Cost-Effective as Surgical Aortic Valve Replacement?经导管主动脉瓣植入术与外科主动脉瓣置换术的成本效益相同吗？
Am J Cardiol. 2015 Sep 15;116(6):996-7. doi: 10.1016/j.amjcard.2015.06.031. Epub 2015 Jul 17.
5
Is transcatheter aortic valve replacement a profitable procedure in a high-volume French hospital?经导管主动脉瓣置换术在一家法国高容量医院是否盈利？
Arch Cardiovasc Dis. 2018 Aug-Sep;111(8-9):534-540. doi: 10.1016/j.acvd.2018.01.003. Epub 2018 Mar 16.
6
Transcatheter aortic valve replacement with Lotus valve: initial experience.采用Lotus瓣膜进行经导管主动脉瓣置换术：初步经验。
Rev Esp Cardiol (Engl Ed). 2014 Nov;67(11):956-8. doi: 10.1016/j.rec.2014.06.011. Epub 2014 Sep 18.
7
Costs and in-hospital outcomes of transcatheter aortic valve implantation versus surgical aortic valve replacement in commercial cases using a propensity score matched model.使用倾向评分匹配模型对商业案例中经导管主动脉瓣植入术与外科主动脉瓣置换术的成本及院内结局进行比较
Am J Cardiol. 2015 May 15;115(10):1443-7. doi: 10.1016/j.amjcard.2015.02.026. Epub 2015 Feb 18.
8
Economic Implications of Transcatheter Aortic Valve Replacement in Patients at Intermediate Surgical Risk.经导管主动脉瓣置换术对手术风险中等患者的经济影响
Circulation. 2016 Nov 8;134(19):1416-1418. doi: 10.1161/CIRCULATIONAHA.116.021962.
9
Lower cardiovascular mortality with Medtronic CoreValve versus Edwards SAPIEN in patients with aortic valve stenosis undergoing transcatheter aortic valve implantation.在接受经导管主动脉瓣植入术的主动脉瓣狭窄患者中，与爱德华兹SAPIEN瓣膜相比，美敦力CoreValve瓣膜可降低心血管死亡率。
Int J Cardiol. 2014 Dec 15;177(2):520-2. doi: 10.1016/j.ijcard.2014.08.089. Epub 2014 Aug 23.
10
[The Costs, Cognitive abilities and Quality of life after transcatheter aortic valve implantation and surgical aortic valve replacement (CCQ) study in the current clinical scenario].
G Ital Cardiol (Rome). 2016 Dec;17(12 Suppl 1):3S-4. doi: 10.1714/2613.26896.
引用本文的文献
1
Cost-effectiveness analysis in cardiac surgery: A review of its concepts and methodologies.心脏外科手术中的成本效益分析：概念与方法综述。
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1671-1681.e11. doi: 10.1016/j.jtcvs.2017.11.018. Epub 2017 Nov 15.
2
Transcatheter aortic valve implantation economics: a grisly reality.经导管主动脉瓣植入术的经济学：一个残酷的现实。
Ann Cardiothorac Surg. 2017 Sep;6(5):516-523. doi: 10.21037/acs.2017.07.02.
3
Championing Effectiveness Before Cost-Effectiveness.在考虑成本效益之前先倡导有效性。
JACC Heart Fail. 2016 May;4(5):376-9. doi: 10.1016/j.jchf.2016.02.001. Epub 2016 Mar 30.
本文引用的文献
1
Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.经导管主动脉瓣置换术使用自膨胀式人工瓣膜与外科主动脉瓣置换术的成本效益分析
J Am Coll Cardiol. 2016 Jan 5;67(1):29-38. doi: 10.1016/j.jacc.2015.10.046.
2
Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis.无症状重度主动脉瓣狭窄患者的初始外科手术与保守治疗策略。
J Am Coll Cardiol. 2015 Dec 29;66(25):2827-2838. doi: 10.1016/j.jacc.2015.10.001. Epub 2015 Oct 15.
3
Specialty Pharmaceuticals for Hyperlipidemia--Impact on Insurance Premiums.用于治疗高脂血症的专科药物——对保险费的影响。
N Engl J Med. 2015 Oct 22;373(17):1591-3. doi: 10.1056/NEJMp1509863. Epub 2015 Oct 7.
4
Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.手术风险增加的重度主动脉瓣狭窄患者经导管或外科主动脉瓣置换术后的健康状况：CoreValve美国关键试验的结果
JACC Cardiovasc Interv. 2015 Aug 17;8(9):1207-1217. doi: 10.1016/j.jcin.2015.04.018.
5
2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement.接受外科或自膨式经导管主动脉瓣置换术患者的 2 年结果。
J Am Coll Cardiol. 2015 Jul 14;66(2):113-21. doi: 10.1016/j.jacc.2015.05.017. Epub 2015 Jun 5.
6
Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.更新成本效益——每质量调整生命年5万美元阈值令人好奇的韧性。
N Engl J Med. 2014 Aug 28;371(9):796-7. doi: 10.1056/NEJMp1405158.
7
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.美国心脏病学会/美国心脏协会关于临床实践指南和绩效指标中成本/价值方法的声明：美国心脏病学会/美国心脏协会绩效指标工作组和实践指南工作组的报告
J Am Coll Cardiol. 2014 Jun 3;63(21):2304-22. doi: 10.1016/j.jacc.2014.03.016. Epub 2014 Mar 27.
8
Transcatheter aortic-valve replacement with a self-expanding prosthesis.经导管主动脉瓣置换术，使用自扩张假体。
N Engl J Med. 2014 May 8;370(19):1790-8. doi: 10.1056/NEJMoa1400590. Epub 2014 Mar 29.
9
Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.经导管主动脉瓣置换术使用自扩张生物瓣治疗手术高危重度主动脉瓣狭窄患者。
J Am Coll Cardiol. 2014 May 20;63(19):1972-81. doi: 10.1016/j.jacc.2014.02.556. Epub 2014 Mar 19.
10
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2014年美国心脏协会/美国心脏病学会瓣膜性心脏病患者管理指南：美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Jun 10;63(22):e57-185. doi: 10.1016/j.jacc.2014.02.536. Epub 2014 Mar 3.
Zotero 插件